Cargando…
Antibiotics as immunomodulators: a potential pharmacologic approach for ARDS treatment
First described in the mid-1960s, acute respiratory distress syndrome (ARDS) is a life-threatening form of respiratory failure with an overall mortality rate of approximately 40%. Despite significant advances in the understanding and treatment of ARDS, no substantive pharmacologic therapy has proven...
Autores principales: | Sauer, Andrea, Peukert, Konrad, Putensen, Christian, Bode, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489085/ https://www.ncbi.nlm.nih.gov/pubmed/34615700 http://dx.doi.org/10.1183/16000617.0093-2021 |
Ejemplares similares
-
Immunomodulation by Tetracyclines in the Critically Ill: An Emerging Treatment Option?
por: Sauer, Andrea, et al.
Publicado: (2022) -
SP-D Serum Levels Reveal Distinct Epithelial Damage in Direct Human ARDS
por: Peukert, Konrad, et al.
Publicado: (2021) -
Increased Alveolar Epithelial Damage Markers and Inflammasome-Regulated Cytokines Are Associated with Pulmonary Superinfection in ARDS
por: Peukert, Konrad, et al.
Publicado: (2023) -
Novel Pharmacologic Approaches for the Treatment of ARDS
por: Herrero, R., et al.
Publicado: (2014) -
Tetracycline ameliorates silica-induced pulmonary inflammation and fibrosis via inhibition of caspase-1
por: Peukert, Konrad, et al.
Publicado: (2022)